Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,824 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Viral lymphomagenesis.
Ahmed N, Heslop HE. Ahmed N, et al. Curr Opin Hematol. 2006 Jul;13(4):254-9. doi: 10.1097/01.moh.0000231423.38525.fe. Curr Opin Hematol. 2006. PMID: 16755222 Review.
Medulloblastoma-biology and microenvironment: a review.
Byrd T, Grossman RG, Ahmed N. Byrd T, et al. Among authors: ahmed n. Pediatr Hematol Oncol. 2012 Sep;29(6):495-506. doi: 10.3109/08880018.2012.698372. Epub 2012 Jun 28. Pediatr Hematol Oncol. 2012. PMID: 22742590 Free PMC article. Review.
Adoptive cell therapies for glioblastoma.
Bielamowicz K, Khawja S, Ahmed N. Bielamowicz K, et al. Among authors: ahmed n. Front Oncol. 2013 Nov 11;3:275. doi: 10.3389/fonc.2013.00275. eCollection 2013. Front Oncol. 2013. PMID: 24273748 Free PMC article. Review.
Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme.
Mukherjee M, Byrd T, Brawley VS, Bielamowicz K, Li XN, Merchant F, Maitra S, Sumazin P, Fuller G, Kew Y, Sun D, Powell SZ, Ahmed N, Zhang N, Pati D. Mukherjee M, et al. Among authors: ahmed n. J Neurooncol. 2014 Aug;119(1):27-35. doi: 10.1007/s11060-014-1458-6. Epub 2014 May 4. J Neurooncol. 2014. PMID: 24792645 Free PMC article.
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
Wakefield A, Pignata A, Ghazi A, Ashoori A, Hegde M, Landi D, Gray T, Scheurer ME, Chintagumpala M, Adesina A, Gottschalk S, Hicks J, Powell SZ, Ahmed N. Wakefield A, et al. Among authors: ahmed n. J Neurooncol. 2015 Nov;125(2):307-15. doi: 10.1007/s11060-015-1905-z. Epub 2015 Sep 4. J Neurooncol. 2015. PMID: 26341370 Free PMC article.
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S. Ahmed N, et al. JAMA Oncol. 2017 Aug 1;3(8):1094-1101. doi: 10.1001/jamaoncol.2017.0184. JAMA Oncol. 2017. PMID: 28426845 Free PMC article. Clinical Trial.
2,824 results